We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.50 | 38.50 | 38.80 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.68 | 123.72M |
TIDMACRL
RNS Number : 7580I
Accrol Group Holdings PLC
02 September 2016
2(nd) September 2016
Accrol Group Holdings plc (the "Company" or "Accrol")
New manufacturing facility in Leyland, Lancashire to support the Company's growth plans
Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce that it has reached an agreement with Lancashire County Developments (Property) Ltd (the economic development arm of Lancashire County Council) to lease a new 168,000 sq. ft. facility in Leyland, Lancashire. The new facility will support the Company's continued growth with both the Discounters and the Major Multiples in the UK.
The new property will initially house two high speed tissue converting lines purchased by Accrol in April 2016 and also provide finished goods warehousing space, with potential to add two further converting lines if required.
Installation and commissioning of the first two lines will take place during late 2016, with manufacturing planned to start in January 2017. The project is expected to create around 80 new jobs.
Commenting on the new facilities, Steve Crossley, Accrol's CEO said:
"This additional capacity underlines our strategy of investment ahead of growth in state-of-the-art machinery and facilities. It will position Accrol to benefit from underlying organic growth in the Discount sector and enable further growth with the Major Multiples. At the same time, we will focus on improving efficiency at the existing Blackburn sites to further increase our total capacity."
For further information please contact: Zeus Capital Limited (Nominated Adviser & Broker) Dan Bate / Jonathan Sharp Tel: +44 (0) 161 831 1512 Dominic King / Adam Pollock Tel: +44 (0) 20 3829 / Mike Seabrook 5000 Camarco (Media enquiries) Jennifer Renwick / Billy Tel: +44 (0) 203 757 Clegg 4994
Notes to Editors
Accrol manufactures toilet rolls, kitchen rolls and facial tissues as well as other tissue products at the Company's 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 16 million units per week and supplies some of the UK's largest retailers, providing both Accrol branded and Private Label products.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFVRAAILIIR
(END) Dow Jones Newswires
September 02, 2016 02:00 ET (06:00 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions